RegalCare Management Settled Overbilling Claims for $1 Million
Healthcare operators face scrutiny over record-keeping and billing practices after this False Claims Act settlement.
Updated on Sept. 23, 2026 in Healthcare
Live Poll
Should healthcare providers face stricter oversight to prevent fraudulent billing of government programs?
RegalCare Management Group and two executives agreed to pay $1 million to resolve allegations of submitting medically unnecessary claims to Medicare and Massachusetts Medicaid. The settlement stems from improper billing practices identified between 2018 and 2023.
Why it matters
This settlement highlights the severe compliance risks associated with submitting therapy claims without clinical authorization or finalized assessment documentation. It underscores why federal regulators continue to prioritize investigations into inflated billing for services not supported by patient need.
The $1 million settlement resolves allegations of overbilling Medicare and Medicaid, with a whistleblower receiving a $165,000 share of the total proceeds.
The players
RegalCare Management Group
A healthcare management company that oversees nursing and long-term care facilities.
Hector Caraballo
An executive at RegalCare Management Group involved in patient record modifications.
Eliyahu Mirlis
An executive at RegalCare Management Group who managed billing submission processes.
Stern Therapy
A therapy services provider that reached a separate settlement for overbilling conspiracy.
The details
RegalCare was alleged to have submitted claims for 'Ultra High RUG' therapy services that lacked clinical justification. Executive Hector Caraballo reportedly modified patient records without authorization or consultation, while Eliyahu Mirlis directed staff to submit billing before necessary patient assessment forms were completed.
Timeline
Between 2018 and 2023, the period when improper claims were submitted.
In February 2025, the False Claims Act complaint was filed.
In March 2026, the United States finalized a separate settlement with Stern Therapy regarding overbilling.
On September 22, 2026, the RegalCare settlement was officially announced.
Market Landscape
This settlement follows the enforcement pattern established by the False Claims Act, which creates significant financial liability for companies that submit unsupported claims. It echoes the recent federal oversight trend seen in the March 2026 settlement with Stern Therapy.
Operators must ensure that clinical assessments are finalized and documented prior to the submission of any billing claims. Internal audits should regularly confirm that therapy services align strictly with patient necessity to mitigate False Claims Act exposure.
The takeaway
The case emphasizes that documentation discrepancies in therapy services carry heavy financial and legal penalties. Operators should prioritize rigorous oversight of billing cycles and ensure that all patient assessment modifications are clinically authorized and transparent.
Further reading
For more on industry compliance standards, see Healthcare.
Source note: This article includes information reported by The United States Department of Justice.
Live Poll
Should healthcare providers face stricter oversight to prevent fraudulent billing of government programs?
